Norepinephrine does not alter NPY and POMC mRNA expression in neonatal chicks.

Norepinephrine (NE), synthesized in both the central and peripheral nervous system, is involved in food intake regulation of both mammals and chickens. Neuropeptide Y (NPY), a potent orexigenic peptide, is colocalized with NE neurons in the central and peripheral nervous system, suggesting an interaction. Proopiomelanocortin (POMC) is the precursor of alpha-melanocyte stimulating hormone, a potent anorexigenic peptide synthesized in the hypothalamus. In this study, two experiments were conducted to examine the effect of intracerebroventricular (ICV) injection of NE on appetite mediators in neonatal chicks (Gallus gallus). Experiment 1 was done to confirm the effect of centrally administered NE (0, 25, 50, and 100 microg) on food intake following a 3h fast, and to determine the change in NPY mRNA expression in the central nervous system (CNS). In Experiment 2, chicks fed ad libitum were treated ICV with NE (50 microg) to determine if changes occurred in brain NPY and POMC mRNA levels. In Experiment 1, the ICV injection of NE dose-dependently reduced food intake, but there was no change in NPY mRNA expression in the CNS. In Experiment 2, there was no significant change in NPY and POMC mRNA expression between the control and NE-treated group, indicating that ICV injection of NE may not be associated with changes in NPY or POMC gene expression.

Central L-alanine reduces energy expenditure with a hypnotic effect under an acute stressful condition in neonatal chicks.

Recently, we reported that intracerebroventricular (i.c.v.) injection of L-alanine attenuated the stress response under an acute stressful condition in chicks. However, no information of L-alanine was available for the influence on energy expenditure and changes in the posture under stressful conditions. The purpose of the present study was to clarify whether central L-alanine affects heat production (HP) of neonatal chicks, and whether HP is correlated with the behavior after isolation-induced stress. The i.c.v. injection of L-alanine (0.8 micromol) decreased oxygen consumption, carbon dioxide production and HP shortly after injection. Central L-alanine reduced the posture for active wakefulness, but increased the posture for sitting motionless with head drooped (sleeping posture). The present study demonstrates that central L-alanine decreases energy expenditure and causes a hypnotic effect in chicks exposed to an acute stressful condition.

Oral administration of Excitin-1 (beta-alanyl-L-leucine) alters behavior and brain monoamine and amino acid concentrations in rats.

We previously demonstrated that beta-alanyl-branched chain amino acids have excitatory effects. Therefore, we named beta-alanyl-L-leucine, beta-alanyl-L-isoleucine and beta-alanyl-L-valine as Excitin-1, -2, and -3 , respectively. Since there is little known about the effects of Excitins, we clarified whether oral administration of Excitin-1 affects behavior in rats, alters the monoamine and amino acid levels in the central nervous system, whether Excitin-1 is incorporated into the brain, and how long it remains in the blood. Excitin-1 increased motor behavior, increasing the distance of path and number of rearings in the open field. Excitin-1 influenced some monoamine and amino acid levels in the cerebral cortex and hypothalamus. Following oral administration, Excitin-1 was detected in the cerebral cortex, hypothalamus, hippocampus and olfactory bulb. In the plasma, Excitin-1 and its metabolites beta-alanine and L-leucine were recorded. The present study demonstrated that Excitin-1 was incorporated in the brain and promoted behavioral changes in rats.

l-Serine induces sedative and hypnotic effects acting at GABA(A) receptors in neonatal chicks.

Intracerebroventricular injection of l-serine has been shown to have sedative and hypnotic effects on neonatal chicks exposed to acute stressful conditions. However, the mechanism by which l-serine induces these effects is unclear. The present study was conducted to clarify the mechanism by l-serine. The involvement of gamma-aminobutyric acid (GABA)(A) receptors on the effect of l-serine was investigated using the GABA(A) receptor antagonist picrotoxin. Co-administration of picrotoxin attenuated the sedative and hypnotic effect of l-serine. Further, we also investigated the involvement of glycine receptors since l-serine is suggested to act as the alpha-homomeric glycine receptor agonist. Glycine similarly induced sedative and hypnotic effects in chicks, but its effect was attenuated by the glycine receptor antagonist strychnine. Therefore, whether the effect of l-serine was mediated through the glycine receptor was investigated using l-serine and strychnine. The effect of l-serine was inhibited by picrotoxin, but not strychnine. It appears that l-serine induces sedative and hypnotic effects by enhancing inhibitory neurotransmission via GABA(A) receptors.

Reverse structure of carnosine-induced sedative and hypnotic effects in the chick under acute stress.

In the central nervous system, beta-alanine is thought to act as an inhibitory neurotransmitter, but the role or precise mechanism of beta-alanine in the brain has not been clearly defined. beta-Alanine is found in high levels in the chicken brain as a component of the dipeptides carnosine (beta-alanyl-L-histidine) and anserine, or as a free amino acid. We focused on the position of beta-alanine, i.e., at the carboxyl terminus. In Experiment 1, the central effects of glycyl-beta-alanine, L-histidyl-beta-alanine and L-valyl-beta-alanine were compared with a saline control in chicks. L-Histidyl-beta-alanine significantly induced sedative and hypnotic effects. In Experiment 2, the effects of carnosine, its reverse (L-histidyl-beta-alanine), and their combination were investigated. Central carnosine-induced hyperactivity while reverse carnosine-induced hypoactivity, and the behaviors were intermediate following the combination of the two peptides. Finally, the central effect of reverse carnosine was compared with beta-alanine alone and L-seryl-beta-alanine in Experiment 3. Reverse carnosine showed similar effects to beta-alanine. In conclusion, L-histidyl-beta-alanine not only has the reverse structure of carnosine, but also reverse function. Thus, we propose to name reverse carnosine (L-histidyl-beta-alanine) rev-carnosine.

Central administration of dipeptides, beta-alanyl-BCAAs, induces hyperactivity in chicks.

BACKGROUND: Carnosine (beta-alanyl-L-histidine) is a putative neurotransmitter and has a possible role in neuron-glia cell interactions. Previously, we reported that carnosine induced hyperactivity in chicks when intracerebroventricularly (i.c.v.) administered. In the present study, we focused on other beta-alanyl dipeptides to determine if they have novel functions. RESULTS: In Experiment 1, i.c.v. injection of beta-alanyl-L-leucine, but not beta-alanyl-glycine, induced hyperactivity behavior as observed with carnosine. Both carnosine and beta-alanyl-L-leucine stimulated corticosterone release. Thus, dipeptides of beta-alanyl-branched chain amino acids were compared in Experiment 2. The i.c.v. injection of beta-alanyl-L-isoleucine caused a similar response as beta-alanyl-L-leucine, but beta-alanyl-L-valine was somewhat less effective than the other two dipeptides. beta-Alanyl-L-leucine strongly stimulated, and the other two dipeptides tended to stimulate, corticosterone release. CONCLUSION: These results suggest that central beta-alanyl-branched chain amino acid stimulates activity in chicks through the hypothalamus-pituitary-adrenal axis. We named beta-alanyl-L-leucine, beta-alanyl-L-isoleucine and beta-alanyl-L-valine as Excitin-1, Excitin-2 and Excitin-3, respectively.

Oral administration of L-serine reduces the locomotor activity of socially isolated rats.

L-Serine is considered a functional amino acid in the central nervous system, since intracerebroventricular injection of L-serine induced sedative and hypnotic effects in neonatal chicks exposed to acute stressful conditions. Accordingly, L-serine is a candidate anti-stress factor, but the effect of daily intake of L-serine on behavior of animals exposed to chronic stress has not been investigated. In the present study, we exposed rats to social isolation stress for 4 weeks, and home cage test and open field test were concluded to evaluate the effect of L-serine on behavior. To investigate L-serine supplementation modifies the brain L-serine and its metabolite contents, free amino acid contents were measured by a high performance liquid chromatography. L-Serine in the drinking water increased L-serine levels in some brain areas, but changes in its metabolites were almost negligible. L-Serine decreased locomotor activity in rats exposed to a familiar environment. In addition, L-serine decreased exploratory behavior of isolated rats, even in a novel environment. Our results could suggest that daily intake of L-serine can attenuate symptoms induced by chronic stress.

Central L-cysteine induces sleep, and D-cysteine induces sleep and abnormal behavior during acute stress in neonatal chicks.

L-cysteine (L-Cys) is a non-essential and glycogenic amino acid. Previously, we reported that the intracerebroventricular (i.c.v.) injection of L-Cys induced sedative effects under isolation-induced stress in neonatal chicks. L-Cys has an optical isomer, D-Cys. The aim of this study was to clarify the effect of L-Cys and D-Cys during a stressful condition in chicks. The i.c.v. injection of L-Cys and D-Cys (0.84 micromol) decreased both distress vocalization and spontaneous activity induced by isolation. However, the two cysteine isomers induced different behaviors. L-Cys increased sleep-like behavior while D-Cys caused abnormal behavior including syncope as well as sleep-like behavior. In conclusion, while both L-Cys and D-Cys caused a sedative effect when injected i.c.v, D-Cys caused abnormal behavior and may be detrimental to neonatal chicks.

Reduced glutathione decreases energy expenditure in chicks exposed to separation stress.

Recently, we reported that intracerebroventricular (i.c.v.) injection of reduced glutathione (GSH) induces hypnotic and sedative effects under an acute stressful condition in chicks. However, no information is available on the effects of GSH on energy expenditure (EE) under stressful conditions. The purpose of the present study was to clarify whether i.c.v. injection of GSH affects EE of neonatal chicks, and whether EE is correlated with behavioral changes after isolation-induced stress. The EE was rapidly decreased by i.c.v. injection of GSH, but was increased 27 min after injection. This change in EE was correlated with behavioral changes in which GSH induced hypnotic and sedative effects shortly after injection, followed by a period in which activity increased. The present study demonstrates that central GSH initially causes lowered EE through hypnotic and sedative effects under an acute stressful condition in chicks.

Intracerebroventricular injection of L-aspartic acid and L-asparagine induces sedative effects under an acute stressful condition in neonatal chicks.

The present study was conducted to clarify the central functions of L-aspartic acid (Asp) and L-asparagine (Asn) during an acute stressful condition in chicks. Intracerebroventricular (i.c.v.) injection of Asp and Asn (0.84 micromol) attenuated the vocalization that normally occurs during social separation stress. Asp decreased the time spent in active wakefulness and induced sedation. Asn had a similar effect to Asp, although somewhat weaker. However, i.c.v. injection of Asp and Asn further enhanced plasma corticosterone release under social separation stress. Taken together, the i.c.v. injection of Asp and Asn has sedative effects under an acute stressful condition, which does not involve the hypothalamic-pituitary-adrenal axis.